SG Sides With Teva In High Court Skinny Label Patent Case

By Hailey Konnath (March 29, 2023, 11:17 PM EDT) — The U.S. solicitor general said Wednesday that the U.S. Supreme Court should grant Teva’s request for review of a Federal Circuit decision on so-called skinny labels for pharmaceuticals, saying the appellate court’s finding threatens the availability of lower-cost generic drugs….